# Obese Patients With Untreated Dyslipidemias

> **NCT00029835** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 1033 (actual)

## Conditions studied

- Obesity
- Dyslipidemia

## Interventions

- **DRUG:** Rimonabant (SR141716)

## Key facts

- **NCT ID:** NCT00029835
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 1033 (ACTUAL)
- **Last updated:** 2009-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00029835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00029835, "Obese Patients With Untreated Dyslipidemias". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00029835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*